TSL.L Regulatory News (TSL)

23 Nov 2006 12:31

Tissue Science Laboratories PLC23 November 2006 NOTIFICATION OF MAJOR INTERESTS IN SHARES 1. Name of listed company Tissue Science Laboratories plc 2. Name of shareholder having a major interest Aviva plc and its subsidiaries 3. Please state whether notification indicates that it is regarding the holdingof the shareholder named in 2 above; in respect of a nonbeneficial interest; orin the case of an individual holder if it is a holding of that person's spouseor children under the age of 18 As in 2 above 4. Name of the registered holder(s) and, if more than one holder, the number ofshares held by each of them Morley Fund Management Ltd:BNY Norwich Union Nominees Limited 169,638*Chase GA Group Nominees Limited 489,775*CUIM Nominee Limited 159,782* BNP Paribas - London 390,000Vidacos Nominees Limited 2,442,939 * denotes beneficial interest 5. Number of shares / amount of stock acquired n/a 6 Percentage of issued class (any treasury shares held by the listed companyshould not be taken into account when calculating percentage) n/a 7. Number of shares / amount of stock disposed n/a 8 Percentage of issued class (any treasury shares held by the listed companyshould not be taken into account when calculating percentage) n/a 9. Class of security Ordinary GBP0.10 shares 10. Date of transaction 16 November 2006 11. Date listed company informed 20 November 2006 12. Total holding following this notification 3,652,134 13. Total percentage holding of issued class following this notification (anytreasury shares held by the listed company should not be taken into account whencalculating percentage) 10.55% 14. Any additional information Figures are based on an increased number of shares in issue of 34,601,657 15. Name of contact and telephone number for queries David Jennings, Finance Director Tel: 01252 333 002 16. Name and signature of duly authorised officer of the listed companyresponsible for making this notification As in 15 above Date of notification 23 November 2006 The FSA does not give any express or implied warranty as to the accuracy of thisdocument or material and does not accept any liability for error or omission.The FSA is not liable for any damages (including, without limitation, damagesfor loss of business or loss of profits) arising in contract, tort or otherwisefrom the use of or inability to use this document, or any material contained init, or from any action or decision taken as a result of using this document orany such material. This information is provided by RNS The company news service from the London Stock Exchange